There is now a critical mass of experts in this field and things are moving much faster, Stanford scientists say.

This is the first time that skeletal stem cells, which had been observed in rodents, have been identified in humans.

Genetic data highlights the previously understated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay.

The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.

Manipulating yeast with optogenetics and microfluidics to explore the MAP kinase pathway may be key for drug discovery.

An antioxidant in green tea called epigallocatechin gallate has been found to have a surprising use: sneaking therapeutic RNAs into cells.

A growing number of life science businesses are turning to greater supply chain collaboration for benefits like accelerated time to market, improved quality, reduced risk and more rapid and widespread innovation. But while 68% of executives in this industry say active and meaningful engagement with suppliers is essential to success, far too many, over a third, struggle to implement it.

Antimicrobials have revolutionized medicine by enabling treatments for diseases that would once have proven fatal, however,they have since proven to be a double-edged sword.

Bacteriophage (phage) are obligate intracellular viruses that specifically infect bacteria. Here we take an overview of their structure, life-cycle and the role they have played in advancing science and medicine.

They say 'a picture is worth a thousand words.' Is this true for cell images?

Against a background where analysts in the pharmaceutical industry are increasingly looking for accurate, easy-to-use and scalable methods, nuclear magnetic resonance spectroscopy has become established as a leading technique.

The pharma industry is being disrupted in multiple ways. Data has never been more accessible and the speed at which it is flowing has left the industry reeling. Fundamental to the success of these advances is the need to integrate data from diverse sources and leverage predictive analytics to drive informed, real-time decisions. This article explores how pharma can maximize the value of different data types to advance research.